GPs in England will be able to prescribe weight loss jabs for the first time on the NHS on Monday, as the health service ...

In adults with obesity and prediabetes, weight loss achieved with tirzepatide was sustained at more than 3 years, according ...

BrightGene Pharmaceutical has scored an early win in its push to topple the big beasts of the GLP-1 field. | BrightGene ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Scholar Rock's Apitegromab excels in Phase 2 trials, aiding muscle preservation with Tirzepatide. Click here to read why I ...

The NHS has just announced a major change made to Mounjaro access as 1,600,000 people are now expected to receive the weight ...

With semaglutide and tirzepatide dosed once weekly, their estimated average yearly costs in the U.S. are $14,080 and $8,126, ...

New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and ...

The American College of Cardiology has issued new guidelines recommending weight management medications as first-line ...

For patients with obesity, clinicians should move beyond a "try and fail" approach to lifestyle interventions and prioritize ...

The American College of Cardiology has issued a Concise Clinical Guidance (CCG) document to aid clinicians in the use of ...